Brevetti EPO No.3883579 2025.12.24
Brevetti EPO
(10) Registration Number and Date
2026000101 2026.03.03
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000101 2019.11.18
(40) Publication Number and Date
SM /T/2026/000101 2026.03.03
(30) Priority Details
US 201962821376 P
2019.03.20
US 201962865819 P
2019.06.24
US 201862769355 P
2018.11.19
(51) IPC Classes
(72) Inventor
(IT) CANON, Jude Robert : One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A, Thousand Oaks, CA 91320-1799, US
(IT) LIPFORD, James Russell : One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A, Thousand Oaks, CA 91320-1799, US
(IT) REX, Karen Louise : One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A, Thousand Oaks, CA 91320-1799, US
(74) Representative Name
(IT) BUSCA, Andrea : Strada Caiese, 30, 47891 Dogana RSM, SM
(54) Title
(IT) TERAPIA DI COMBINAZIONE INCLUDENTE UN INIBITORE DI KRAS-G12C E UNO O PIÙ AGENTI FARMACEUTICAMENTE ATTIVI AGGIUNTIVI PER IL TRATTAMENTO DI CANCRI
(EN) COMBINATION THERAPY INCLUDING A KRAS-G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
(57) Abstract
(58) Citations
Document Type Date Action
Event NameDateStatus
Filing2019.11.18Filed
Brevetto EPO concesso2026.03.03Registered